686617

Source:http://linkedlifedata.com/resource/pubmed/id/686617

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008996, umls-concept:C0024141, umls-concept:C0087111, umls-concept:C0205191, umls-concept:C0341628, umls-concept:C0700047
pubmed:issue	4
pubmed:dateCreated	1978-10-25
pubmed:abstractText	Lamprene (Clofazimine) was administered over a period of three months, at a dose of 100 mg to 200 mg per day, to six patients with chronic lupus erythematosus. Remission was observed in these six cases, without any side-effect.
pubmed:language	fre
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7702013
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Clofazimine
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0151-9638
pubmed:author	pubmed-author:AlbarelNN, pubmed-author:BonaféJ LJL, pubmed-author:ChristolBB, pubmed-author:DupréAA, pubmed-author:LassèreJJ
pubmed:issnType	Print
pubmed:volume	105
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	423-5
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:686617-Adult, pubmed-meshheading:686617-Chronic Disease, pubmed-meshheading:686617-Clofazimine, pubmed-meshheading:686617-Dose-Response Relationship, Drug, pubmed-meshheading:686617-Drug Evaluation, pubmed-meshheading:686617-Female, pubmed-meshheading:686617-Humans, pubmed-meshheading:686617-Lupus Erythematosus, Discoid, pubmed-meshheading:686617-Male, pubmed-meshheading:686617-Middle Aged
pubmed:year	1978
pubmed:articleTitle	[Lamprene (Clofazimine) treatment of chronic lupus erythematoides (author's transl)].
pubmed:publicationType	Journal Article, English Abstract